Vascular Endothelial Dysfunction in Patients with Newly Diagnosed Type 2 Diabetes and Effects of 2-Year and 5-Year Multifactorial Intervention

Jing Tian,Yanling Wen,Li Yan,Hua Cheng,Haiyun Yang,Jingfeng Wang,Hani Kozman,Daniel Villarreal,Kan Liu
DOI: https://doi.org/10.1111/j.1540-8175.2011.01514.x
2011-01-01
Echocardiography
Abstract:Objectives: Investigate short‐ and long‐term effect of multifactorial intervention on endothelial dysfunction in patients with newly diagnosed type 2 diabetes. Background: Whether multifactorial intervention reduces cardiovascular risk in type 2 diabetes is largely controversial, partially because of lack of reliable method for endothelial dysfunction detection. Using high‐resolution ultrasonographical flow‐mediated vasodilatation (FMD), we completed a 5‐year randomized prospective intervention trial in patients with newly diagnosed type 2 diabetes. We have studied the effect of multifactorial intervention therapy on their endothelial dysfunction. Methods: One hundred eight patients with newly diagnosed type 2 diabetes, and 83 healthy subjects received measurement of brachial artery FMD and endothelium‐independent dilatation (EID). Diabetic patients were assigned into four groups, treated with: (A) hypoglycemic and antihypertensive agents, (B) hypoglycemic, antihypertensive and lipid‐lowering agents, (C) hypoglycemic, antihypertensive and lipid‐lowering agents, and vitamin E, and (D) hypoglycemic, antihypertensive and lipid‐lowering agents, and compound salvia tablets. Both FMD and EID were remeasured after 24‐ and 60‐month treatment. Results: FMD in diabetic patients was significantly lower than those in healthy subjects. After 24‐month treatment, there was no FMD change. However, FMD improved significantly after 60‐month treatment. The differences between 24‐ and 60‐month are also significant. EID did not change significantly after both 24‐ and 60‐month treatments. Conclusions: (1) FMD‐detectable endothelial dysfunction exists in newly diagnosed type 2 diabetic patients. (2) Reverse of endothelial function occurs only after long‐term (60‐month) multifactorial intervention. (3) FMD could potentially help early identification, stratification, and treatment of endothelial dysfunction in type 2 diabetic patients. (Echocardiography 2011;28:1133‐1140)
What problem does this paper attempt to address?